Multilocus analysis of SNP and metabolic data within a given pathway

BMC Genomics

Volumn 7, Issue , 2006, Pages

  Kristensen, Vessela N ^a   Tsalenko, Anya ^b   Geisler, Jurgen ^c   Faldaas, Anne ^a   Grenaker, Grethe Irene ^a   Lingjærde, Ole Christian ^d   Fjeldstad, Ståle ^e   Yakhini, Zohar ^b   Lønning, Per Eystein ^c   Børresen Dale, Anne Lise ^a,d  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b AGILENT TECHNOLOGIES   (United States)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

^e Interagon AS   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; AROMATASE; CYTOCHROME P450 17; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; ESTRADIOL; ESTRONE; ESTRONE SULFATE; PRASTERONE; PRASTERONE SULFATE; STEROID; TESTOSTERONE; CYP1B1 PROTEIN, HUMAN; CYTOCHROME P450; PRIMER DNA; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; AUTOMATED PATTERN RECOGNITION; BODY WEIGHT; CHROMOSOME 15; CHROMOSOME ANALYSIS; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; ESTRONE BLOOD LEVEL; FEMALE; GENE ACTIVITY; GENE IDENTIFICATION; GENE INSERTION; GENE INTERACTION; GENETIC CODE; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; HAPLOTYPE; HORMONE METABOLISM; HUMAN; HUMAN EXPERIMENT; MATHEMATICAL COMPUTING; METHODOLOGY; MONTE CARLO METHOD; MULTIFACTORIAL GENETIC DISORDER; MULTILOCUS SEQUENCE TYPING; NORMAL HUMAN; PENETRANCE; PHENOTYPIC VARIATION; PREDICTION; QUANTITATIVE ANALYSIS; QUANTITATIVE TRAIT; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; STEROID BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL; VALIDATION PROCESS; ARTIFICIAL INTELLIGENCE; BIOLOGY; CHI SQUARE DISTRIBUTION; GENE LINKAGE DISEQUILIBRIUM; GENETICS; GENOMICS; MENOPAUSE; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; NUCLEOTIDE SEQUENCE;

AGED; AROMATASE; ARTIFICIAL INTELLIGENCE; BASE SEQUENCE; CHI-SQUARE DISTRIBUTION; COMPUTATIONAL BIOLOGY; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 ENZYME SYSTEM; DNA PRIMERS; ESTRADIOL; FEMALE; GENOMICS; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MENOPAUSE; MIDDLE AGED; PATTERN RECOGNITION, AUTOMATED; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT, HERITABLE; STATISTICS, NONPARAMETRIC;

EID: 33644590220     PISSN: 14712164     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-7-5     Document Type: Article

References (31)

1. Hoh J, Ott J: Mathematical Multilocus Approaches to Localize Complex Human Trait Genes. Nature Reviews 2003, 4:701-709.
2. Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, Parl FF, Moore JH: Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 2001, 69:138-47.
3. Tsalenko A, Ben-Dor A, Cox N, Jakhini Z: Methods for Analysis and Visualization of SNP genotype data for Complex Diseases. Pac Symp Biocomput 2003, 6:548-561.
4. Hahn LW, Ritchie MD, Moore JH: Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 2003, 19:376-82.
5. Byng MC, Whittaker JC, Cuthbert AP, Mathew CG, Lewis CM: SNP subset selection for genetic association studies. Ann Hum Genet 2003, 67:543-556.
6. Koza JR, Andre D: A case study where biology inspired a solution to a computer science problem. Pac Symp Biocomput 1996, 34:500-511.
7. Nandi S, Guzman RC, Yang J: Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis. Proc Natl Acad Sci USA 2001; 92:3650-3657.
8. Clemons M, Goss P: Estrogen and the risk of breast cancer. N Engl J Med 2001, 344:276-285.
9. Endogenous Hormones and Breast Cancer Collaborative Group: Endogenous sex hormones and breast cancer in postmenopausal women: Reanalysis of nine prospective studies. Journal of the National Cancer Institute 2002, 94:606-616.
10. Endogenous Hormones and Breast Cancer Collaborative Group: Free Estradiol and Breast Cancer Risk in Postmenopausal Women: Comparison of Measured and Calculated Values. Cancer Epidemiol Biomarkers Prev 2003, 12:1457-1461.
11. Trichopoulos D, MacMahan B, Cole P: Menopause and breast cancer risk. Journal of the National Cancer Institute 1972, 48:605-613.
12. Liehr JG: Genotoxicity of the steroidal estrogens estrone and estradiol: possible mechanism of uterine and mammary cancer development. Apmis 2001, 109:S519-S527.
13. Riza E, Dos SS, De Stavola B, Bradlow HL, Sepkovic DW, Linos D, Linos A: Urinary estrogen metabolites and mammographic parenchymal patterns in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2001, 10:627-634.
14. Jacobs S, Lonning PE, Haynes B, Griggs L, Dowsett M: Measurement of aromatisation by a urine technique suitable for the evaluation of aromatase inhibitors in vivo. J Enzyme Inhib 1991, 4:315-325.
15. Huang CS, Chern HD, Chang KJ, Cheng CW, Hsu SM, Shen CY: Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. Cancer Research 1999, 59:4870-4875.
16. Kristensen VN, Kure EH, Erikstein B, Harada N, Borresen-Dale A: Genetic susceptibility and environmental estrogen-like compounds. Mutation Research 2001, 482:77-82.
17. Kristensen VN, Borresen-Dale AL: Molecular epidemiology of breast cancer: genetic variation in steroid hormone metabolism. Mutation Research 2001, 2:30-33.
18. Lonning PE, Helle SI, Johannessen DC, Adlercreutz H, Lien EA, Tally M, Ekse D, Fotsis T, Anker GB, Hall K: Relations between sex hormones, sex hormone binding globulin, insulin-like growth factor-1 and insulin-like growth factor binding protein-1 in post-menopausal breast cancer patients. Clin Endocrinol 1995, 42:23-30.
19. Henderson BE, Feigelson HS: Hormonal carcinogenesis. Carcinogenesis 2000, 21:427-433.
20. Yue W, Santen RJ, Wang JP, Li Y, Verderame MF, Bocchinfuso WP, Korach KS, Devanesan P, Todorovic R, Rogan EG, Cavalieri EL: Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis. J Steroid Biochem Mol Biol 2003, 86:477-486.
21. Shelley S, Tworoger J, Chubak EJ, Aiello CM, Ulrich C, Atkinson Potter JD, Yasui Y, Stapleton PL, Lampe JW, Farin FM, Stanczyk FZ, McTiernan A: Association of CYP17, CYP19, CYP1B1, and COMT Polymorphisms with Serum and Urinary Sex Hormone Concentrations in Postmenopausal Women. Cancer Epidemiol Biomarkers Prev 2004, 13:94-101.
22. Somner J, McLellan S, Cheung J, Mak YT, Frost ML, Knapp KM, Wierzbicki AS, Wheeler M, Fogelman I, Ralston SH, Hampson GN: Polymorphisms in the P450 c17 (17-hydroxylase/17,20-Lyase) and P450 c19 (aromatase) genes: association with serum sex steroid concentrations and bone mineral density in postmenopausal women. J Clin Endocrinol Metab 2004, 89:344-345.
23. Shimada T, Watanabe J, Kawajiri K, Sutter TR, Guengerich FP, Gillam EMJ, Inoue K: Catalytic properties of polymorphic human cytochrome P450 1B1 variants. Carcinogenesis 1999, 20:1607-1613.
24. Shimada T, Watanabe J, Inoue K, Guengerich FP, Gillam EM: Specificity of 17 beta - estradiol and benzo[a]pyrene oxidation by polymorphic human cytochrome P450 1B1 variants substituted at residues 48, 119 and 432. Xenobiotica 2001, 31:163-176.
25. Dunning AM, Dowsett M, Healey CS, Tee L, Luben RN, Folkerd E, Novik KL, Kelemen L, Ogata S, Pharoah PD, Easton DF, Day NE, Ponder BA: Polymorphisms associated with circulating sex hormone levels in postmenopausal women. J Natl Cancer Inst 2004, 96:936-45.
26. Kristensen VN, Harada N, Yoshimura N, Haraldsen E, Lonning PE, Erikstein B, Karesen R, Kristensen T, Borresen-Dale AL: Genetic variants of CYP19 (aromatase) and breast cancer risk. Oncogene 2000, 19:1329-33.
27. Nedelcheva Kristensen V, Andersen TI, Erikstein B, Geitvik G, Skovlund E, Nesland JM, Borresen-Dale AL: Single tube multiplex polymerase chain reaction genotype analysis of GSTM1, GSTT1 and GSTP1: relation of genotypes to TP53 tumor status and clinicopathological variables in breast cancer patients. Pharmacogenetics 1998, 8:441-7.
28. Geisler J, Berntsen H, Lonning PE: A novel HPLC-RIA method for the simultaneous detection of estrone, estradiol and estrone sulphate levels in breast cancer tissue. J Steroid Biochem Mol Biol 2000, 5:259-264.
29. Cascorbi I, Brockmoller J, Roots I: A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Research 1996, 56:4965-4969.
30. Matsui A, Ikeda T, Enomoto K, Nakashima H, Omae K, Watanabe M, Hibi T, Kitajima M: Progression of human breast cancers to the metastatic state in linked to genotypes of catechol-o-methyltransferase. Cancer Letters 2000, 150:23-31.
31. McIntyre LM, Martin ER, Simonsen KL, Kaplan NL: Circumventing Multiple Testing: A Multilocus Monte Carlo Approach to Testing for Association. Genetic Epidemiology 2003, 19:18-29.